Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02620215Phase 4Completed
Phase 4, randomised, open-label trial (2 arms), sponsored by KK Women's and Children's Hospital. Primary endpoint: Adverse events in the first 12 hours after insertion. Started Nov 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02620215.